Dr. Alexander Michael Stessin, MD, PhD

Dr. Stessin practices at Stony Brook University Hospital in Stony Brook, New York, part of Stony Brook University.

Dr. Stessin's NPI, 1598992802, was assigned on June 12, 2009. Dr. Stessin holds New York license 274556.

Dr. Stessin's primary practice is Stony Brook University Hospital, at Health Sciences Center Suny, Stony Brook, NY 11794 in Suffolk County. The practice phone is (631) 444-4000. Dr. Stessin also practices at Stony Brook University Hospital, 101 Nicolls Rd, Stony Brook, NY 11794.

Dr. Stessin's primary practice is Stony Brook University Hospital in Stony Brook, New York, part of Stony Brook University. The medical group on file is Stony Brook Radiation Oncology. Dmand AI also links Dr. Stessin to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stessin practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Stessin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Stessin is licensed in New York.

CMS data shows 1,659 Medicare services from Dr. Stessin across 15 procedure codes in 2024, for 192 Medicare patients. Medicare paid $127,822 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Stessin in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stessin's median patient age at 65, with 75% women.

In 2024, Dr. Stessin wrote 25 Medicare Part D claims for 18 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $264 in total drug cost.

Dr. Stessin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stessin as offering telehealth.

Dmand AI links 22 papers to Dr. Stessin, published from 2012 to 2024. 2015 was the busiest year, with 2. The most frequent topics are SEER Program, Radiotherapy, Adjuvant and Breast Neoplasms. Dr. Stessin has published most often in Int J Radiat Oncol Biol Phys. Dr. Stessin's most frequent co-authors are Samuel Ryu, MD, John Andrew Boockvar, MD and Joseph A. Miccio, MD.

Dmand AI links Dr. Stessin to 3 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Carcinoma, Lobular and Pancreatic Intraductal Neoplasms.

CMS Open Payments shows 1 general payment to Dr. Stessin from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Brainlab, Inc. paid the most, $171.